Susan Knox
Academic Appointments
- Associate Professor, Radiation Oncology - Radiation Therapy
- Member, Bio-X
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Radiation Therapy 875 Blake Wilbur Dr Clinic D Stanford, CA 94305 Tel Work (650) 723-6171 Fax (650) 725-8231Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 725-2720Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Cutaneous (Dermatologic) Oncology
- Cancer> Lymphoma
- Cancer> Radiation Oncology
- Radiation Oncology
- Radiation Therapy
- Lymphoma, Transplantation, Breast Cancer, Targeted Therapies
Administrative Appointments
- Associate Professor (University Tenure Line), Stanford Univ. Sch. of Medicine (1997 - 2010)
- Assistant Professor (University Tenure Line), Stanford Univ. Sch. of Medicine (1990 - 1997)
- Assistant Dean for Medical Student Advising, Stanford Univ. Sch. of Medicine (2002 - 2010)
- Member, Oncological Sciences Study Section Boundaries Team (2001 - 2001)
- Member, Clinical Oncology Study Section (2001 - 2004)
- Reviewer, External Advisory Committee for NIH grant U54 CA 90788 (2001 - 2006)
Honors and Awards
- Clinical Oncology Career Development Award, American Cancer Society (1991-94)
- Lazard Faculty Scholar, Lazard Faculty (1992-93)
- Board of Governors, Stanford Medical Alumni Association (2000-2008)
- Charles F. Kettering Selection Committee, General Motors Cancer Research Foundation (2000-2002)
- Elected Councilor Medicine, Radiation Research Society (2003)
- President, Alumni Association, Stanford University School of Medicine (2005-2007)
Professional Education
| Residency: | Stanford University School of Medicine CA (1990) |
| Fellowship: | Stanford University School of Medicine CA (1989) |
| Internship: | UC Davis Medical Center CA (1986) |
| Medical Education: | Stanford University School of Medicine CA (1985) |
| Post Doc Fellow: | Stanford Univ. Hospital, Medical Oncology (1989) |
| Medical Intern: | UC Davis, California (1986) |
Graduate & Fellowship Program Affiliations
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
- Radioimmunotherapy (RIT) and Systemically Targeted Radiation Therapy
- Low Dose Rate Effects
- Radioprotective Agents, Growth Factors/Receptors
- Oncogenes, Apoptosis & Radiosensitivity
- Apoptosis and Signal Transduction Pathways
- Effects of Radiation on the Immune Response
- Biological Response Modifiers and Novel Targeted Radiosensitizers
- Non-Hodgkin's Lymphomas
- Mycosis Fungoides
- Breast and Prostate Cancer
- Radiation as a component of Tumor Vaccine Strategies
Clinical Trials
- Recruiting Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
- Not Recruiting Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
- Not Recruiting Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
- Not Recruiting Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma
- Not Recruiting Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
Publications
- Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line. Clin Immunol. 2013; (1): 44-55
- A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Transl Oncol. 2012; (6): 404-7
- Abscopal effect in a patient with melanoma. N Engl J Med. 2012; (21): 2035; author reply 2035-6
- Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review. Transl Oncol. 2012; (3): 133-40
- Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clin Cancer Res. 2012; (12): 3366-76
- Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials. Cancer Res. 2012; (10): 2600-8
Help